A randomized, multicentre, double blind, placebo-controlled trial of anti TNF alpha (adalimumab) in refractory hand osteoarthritis. The Dora study - Archive ouverte HAL Accéder directement au contenu
Communication Dans Un Congrès Année : 2013

A randomized, multicentre, double blind, placebo-controlled trial of anti TNF alpha (adalimumab) in refractory hand osteoarthritis. The Dora study

Dates et versions

hal-01509629 , version 1 (18-04-2017)

Identifiants

Citer

X. Chevalier, P. Ravaud, E. Maheu, G. Baron, A. Rialland, et al.. A randomized, multicentre, double blind, placebo-controlled trial of anti TNF alpha (adalimumab) in refractory hand osteoarthritis. The Dora study. 2013 OARSI World Congress, Apr 2013, Philadelphie, United States. ⟨10.1016/j.joca.2013.02.311⟩. ⟨hal-01509629⟩
88 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More